Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertainty.
Maling
T J
TJ
Department of Medicine, Wellington School of Medicine.
D015982:Bias; D015986:Confounding Factors, Epidemiologic; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004363:Drug Utilization; D019317:Evidence-Based Medicine; D006291:Health Policy; D006801:Humans; D009520:New Zealand; D010353:Patient Education as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D045167:Progesterone Congeners / Q000009:adverse effects*; D012107:Research Design; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000209:etiology* / Q000517:prevention & control*
D003277:Contraceptives, Oral, Combined; D045167:Progesterone Congeners